Find Nilotinib Parkinson’s Clinical Trials Instantly

Clinical Trials Find Nilotinib Parkinson’s Clinical Trials Instantly

The Fastest Way To Enroll in a Nilotinib Parkinson’s Clinical Trial

The use of nilotinib for Parkinson’s disease is somewhat a controversial topic. Some of the studies gave contradictory results, so researchers can’t agree on its safety in the treatment of Parkinson’s disease.

Continue reading to discover more about medical surveys and clinical trials that involve nilotinib, see if you are eligible to participate, and learn how to find a clinical trial in just a few steps!

The Purpose of Nilotinib Parkinson’s Clinical Trials

Parkinson’s disease is the second most common neurodegenerative disorder causing motor and non-motor symptoms, loss of dopamine, and additional serious problems. There are treatments, therapies, and drugs used to relieve symptoms of Parkinson’s disease, but it remains incurable. 


Medical researchers rely heavily on clinical trials for exploring new treatments and drugs for Parkinson’s disease. One of the frequently studied drugs is nilotinib.

Nilotinib is a medication used to treat chronic myeloid leukemia, and it was designed to block a protein responsible for its development. Studies have shown that in the case of Parkinson’s disease, nilotinib may eliminate toxic proteins that accumulate in the brain.

What Is a Clinical Trial?

A clinical trial is a type of medical study used to test new drugs or treatments on people. Clinical trials provide invaluable information about the safety and efficiency of the drug or treatment being tested. Participation is voluntary, and there are two types of participants:

  1. Patients who have the disease that is being studied
  2. Healthy volunteers

There are a lot of benefits to participating in this kind of research:

  • Getting the best medical care during and after the trial
  • Having access to drugs and treatments that are not available for the general public
  • Being actively involved in the improvement of your health condition
  • Being involved in medical breakthroughs
  • Helping others suffering from the same disease
  • Possibility of getting paid if you’re a healthy volunteer

Phases of a Clinical Trial

Clinical trials are executed through strictly monitored phases, each designed to answer a specific question. They are necessary for researchers to prove that the studied drug is safe and effective and therefore approved by the Food and Drug Administration (FDA). Here is a brief overview of four phases of clinical trials:

Phase Outlines
I Involves a small number of participants and a small dose of the drug
II Involves a larger group of participants and can carry on for a few years
III Focuses on comparing existing drugs or treatments to the ones being tested
IV Involves up to several thousand participants and tests long-term effects of the FDA-approved drug

What Are Participation Requirements for Nilotinib Parkinson’s Disease Studies

Every clinical trial has its own set of requirements—eligibility criteria—that you have to meet to participate. They are different for every research, but some of them are recurring:

  • Age
  • Gender
  • Medical record

If you are diagnosed with Parkinson’s disease, the screening may involve questions about previous treatments, current treatments, or stage of the disease. Researchers will sometimes want to know if you smoke, drink, use substances, or if you’re pregnant or breastfeeding.

Results of Previous Parkinson’s Clinical Trials With Nilotinib

The purpose of studies involving nilotinib is to determine whether it is safe, how it affects patients with Parkinson’s disease, and finding out if it has the potential to treat the symptoms of Parkinson’s effectively. 

Previous studies were not so consistent as they tend to show contrasting findings.

Medical researchers from Georgetown University Medical Center conducted a small phase I research investigating the effects of nilotinib in patients with Parkinson’s disease. Results suggested that nilotinib was safe and effective in treating both motor and cognitive problems in patients living with this illness. Researchers also found that nilotinib increased dopamine production in patients.

Other studies, like the phase II trial conducted by researchers from Northwestern University, gave different results. This study suggested that nilotinib, although safe for use and tolerable by patients, failed to bring any significant benefits to those dealing with Parkinson’s.

DoNotPay Is Your Ally in Finding Nilotinib Parkinson’s Clinical Trials

We understand that finding clinical trials near you can be a time-consuming and tiring process, and we are here to save you some time and trouble! 

DoNotPay is the only platform that finds the best studies based on safety, location, individual preferences, and even estimated compensation. For this, we use short questionnaires and a customized matching algorithm to streamline the search.

Here are the step-by-step instructions:

  1. Open DoNotPay in a web browser
  2. Click on Clinical Trials 
  3. Click on Get Started
  4. Adjust the filters
  5. Select the study you like
  6. Click on Contact Now

You don’t have to contact the researcher, we will send an email on your behalf. That’s not all—you can use our real-time notification feature and get a text message whenever a clinical trial is posted in your area. The best thing is, you can keep all the money you may get since we don’t take cuts or fees!

Alternative Ways of Finding Parkinson’s Clinical Trials That Test Nilotinib

Before deciding on enrollment in a clinical trial, you should consult your doctor and ask for any information or advice they can give you. If you want to find a clinical trial by yourself, you should keep in mind that not all sources are reliable. Look into some other options of finding a Parkinson’s clinical trial in the following table:

Website Benefits

ClinicalTrials.gov

  • Information about all ongoing clinical trials
  • Study details
  • Simple fill-out form 

Parkinson’s Foundation

  • Database of ongoing Parkinson’s clinical trials
  • Results of previous research
  • Information about other Parkinson’s-related events

Things To Consider Before Applying for a Clinical Trial

Choosing to volunteer for a clinical trial is not an easy decision. It is necessary to get yourself informed about all steps of the trial and what comes after. We mentioned some benefits, but you should also consider the risks:

  • You may not get the actual drug because certain clinical trials involve a placebo
  • If you do get the active drug, it may not have an effect on you
  • You may experience side effects
  • It may cause long-term health problems

Consult your doctor, inform yourself on reputable websites dedicated to Parkinson’s disease, and get the details from the clinical trial recruitment team before signing the informed consent. 

By signing that document, you accept all the conditions of the clinical trial you’re about to enroll in. That does not obligate you to stay until the end of the trial—you can quit at any point without consequences.

Other Amazing Features of DoNotPay

If you decide that the nilotinib Parkinson’s clinical trial is not for you, we can help you find other Parkinson’s, Alzheimer’s, or COPD clinical trials. We can offer help in dealing with your medical bills if you’re unemployed or your dental bills. But that is not all—DoNotPay can save you from all those tedious administrative issues that take so much of your time! Open DoNotPay in your web browser, and get your issues resolved!

Here are some of the problems we can help you with:


Want your issue solved now?